Cite

HARVARD Citation

    Moriarty, A. et al. (n.d.). Establishment and characterization of a panel of BRAFV600E colorectal XPDX models from patients with acquired resistance to targeted therapies. European journal of cancer. pp. S14-. [Online]. 
  
Back to record